Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Neurovascular embolization devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and arteriovenous malformations (AVM). GlobalData uses proprietary data and analytics to provide a comprehensive report on the neurovascular embolization devices devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the neurovascular embolization devices market in Japan was Stryker followed by Medtronic, MicroVention, Penumbra, Cerenovus, Balt, B. Braun Melsungen and Integra LifeSciences.
Neurovascular Embolization devices occlude or prevent blood flow to unwanted vessel malformations. Aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils and intrasaccular flow disruptors are tracked under this segment. Aneurysm clips are clothespin-such as clips that are placed at the neck between the blood vessel and aneurysm, blocking blood flow into the ballooned area and preventing future bleeding into the brain from rupture or leakage. Liquid embolic systems are a glue-such as substance that is used to fill the malformation (aneurysm or AVM) in order to redirect blood flow and prevent blood from flowing in. Flow diversion stents are devices that are deployed in the vessel with the malformation, essentially directing blood flow past the aneurysm or AVM and preventing blood from flowing in. Embolization coils are thin wires that, when deposited into the aneurysm, coil and fill up the pocket, essentially blocking blood from flowing in. Intrasaccular flow disruptors are self-expanding nitinol mesh ball implants that are deployed for treatment of wide-neck aneurysms.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the neurovascular embolization devices devices market within Japan was expected to be over $100m in 2022.
For the latest complete market share analysis of neurovascular embolization devices device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
